Abstract:Conventional diagnostic techniques are based on the utilization of analyte sampling, sensing and signaling on separate platforms for detection purposes, which must be integrated to a single step procedure in point of care (POC) testing devices. Due to the expeditious nature of microfluidic platforms, the trend has been shifted toward the implementation of these systems for the detection of analytes in biochemical, clinical and food technology. Microfluidic systems molded with substances such as polymers or glass offer the specific and sensitive detection of infectious and noninfectious diseases by providing innumerable benefits, including less cost, good biological affinity, strong capillary action and simple process of fabrication. In the case of nanosensors for nucleic acid detection, some challenges need to be addressed, such as cellular lysis, isolation and amplification of nucleic acid before its detection. To avoid the utilization of laborious steps for executing these processes, advances have been deployed in this perspective for on-chip sample preparation, amplification and detection by the introduction of an emerging field of modular microfluidics that has multiple advantages over integrated microfluidics. This review emphasizes the significance of microfluidic technology for the nucleic acid detection of infectious and non-infectious diseases. The implementation of isothermal amplification in conjunction with the lateral flow assay greatly increases the binding efficiency of nanoparticles and biomolecules and improves the limit of detection and sensitivity. Most importantly, the deployment of paper-based material made of cellulose reduces the overall cost. Microfluidic technology in nucleic acid testing has been discussed by explicating its applications in different fields. Next-generation diagnostic methods can be improved by using CRISPR/Cas technology in microfluidic systems. This review concludes with the comparison and future prospects of various microfluidic systems, detection methods and plasma separation techniques used in microfluidic devices.

Recent advances in nucleic acid analysis and detection with microfluidic and nanofluidics

Recent advancements in nucleic acid detection with microfluidic chip for molecular diagnostics

Integrated Microfluidic Systems with Sample Preparation and Nucleic Acid Amplification.

Nanotechnology for Ultrafast Nucleic Acid Amplification

Recent Advances in DNA Nanotechnology‐Based Sensing Platforms for Rapid Virus Detection

Advances in DNA/RNA detection using nanotechnology.

Advances in Nucleic Acid Assays for Infectious Disease: The Role of Microfluidic Technology

Advances in the use of nanomaterials for nucleic acid detection in point-of-care testing devices: A review

Advances in Amplification-Free Detection of Nucleic Acid: CRISPR/Cas System As a Powerful Tool.

Advances in Microfluidics and Lab-on-a-Chip Technologies

Nanotechnology-based diagnostic methods for coronavirus: From nucleic acid extraction to amplification

Microfluidic chip and isothermal amplification technologies for the detection of pathogenic nucleic acid

Powerful CRISPR-Based Biosensing Techniques and Their Integration With Microfluidic Platforms

Prospects of Microfluidic Technology in Nucleic Acid Detection Approaches

Advances in Nucleic Acid Amplification-Based Microfluidic Devices for Clinical Microbial Detection

Research Progresses of Nucleic Acid Based Detection of Pathogenic Microorganisms

Advancements in Biosensors for Point-of-Care Testing of Nucleic Acid

Integration of nanomaterials with nucleic acid amplification approaches for biosensing

From single-molecule detection to next-generation sequencing: microfluidic droplets for high-throughput nucleic acid analysis

Recent advances in cascade isothermal amplification techniques for ultra-sensitive nucleic acid detection

On‐Chip Optical Detection of Viruses: A Review